Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. E 7050
2. E-7050
3. E7050 Cpd
4. N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
1. 928037-13-2
2. E-7050
3. Golvatinib (e7050)
4. E7050
5. Unii-516z3yp58e
6. Golvatinib (usan)
7. Golvatinib [usan]
8. 1-n'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
9. 516z3yp58e
10. N-[2-fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
11. Golvatinib Tartrate
12. Golvatinib [usan:inn]
13. N-(2-fluoro-4-{[2-({[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl}amino)pyridin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
14. E7050;golvatinib
15. Golvatinib [inn]
16. E 7050
17. Golvatinib [who-dd]
18. Gtpl7956
19. Schembl1727298
20. Chembl3039525
21. Dtxsid40239155
22. Ex-a830
23. Chebi:177746
24. Hms3651j19
25. Bcp06122
26. Bdbm50100615
27. Mfcd22124462
28. Nsc800107
29. Nsc808608
30. S2859
31. Zinc43195317
32. Akos025404927
33. Ccg-270294
34. Cs-0595
35. Db11977
36. Nsc-800107
37. Nsc-808608
38. Sb16585
39. Ncgc00386210-06
40. Ac-30125
41. As-56994
42. Hy-13068
43. N-(2-fluoro-4-(2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yloxy)phenyl)-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
44. B1439
45. Ft-0700410
46. Sw219690-1
47. D10224
48. E 7050;e7050
49. J-523320
50. Q27077829
51. 1,1-cyclopropanedicarboxamide, N-(2-fluoro-4-((2-(((4-(4-methyl-1-piperazinyl)-1- Piperidinyl)carbonyl)amino)-4-pyridinyl)oxy)phenyl)-n'-(4-fluorophenyl)-
52. 1,1-cyclopropanedicarboxamide, N-(2-fluoro-4-((2-(((4-(4-methyl-1-piperazinyl)-1-piperidinyl)carbonyl)amino)-4-pyridinyl)oxy)phenyl)-n'-(4-fluorophenyl)-
53. 1-n'-[2-luoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-n-(4-luorophenyl)cyclopropane-1,1-dicarboxamide
54. 1-n\'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
55. Gv0
56. N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
57. N-(2-fluoro-4-((2-(((4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonyl)amino)pyridin-4- Yl)oxy)phenyl)-n'-(4- Fluorophenyl)cyclopropane-1,1-dicarboxamide
58. N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yl)oxy)phenyl)-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
59. N-[2-fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-n'-(4-fluorophenyl)cyclopropan E-1,1-dicarboxamide
60. N~1~-{2-fluoro-4-[(2-{[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino}pyridin-4-yl)oxy]phenyl}-n'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
Molecular Weight | 633.7 g/mol |
---|---|
Molecular Formula | C33H37F2N7O4 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 8 |
Exact Mass | 633.28750901 g/mol |
Monoisotopic Mass | 633.28750901 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 1060 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
77
PharmaCompass offers a list of Golvatinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Golvatinib manufacturer or Golvatinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Golvatinib manufacturer or Golvatinib supplier.
PharmaCompass also assists you with knowing the Golvatinib API Price utilized in the formulation of products. Golvatinib API Price is not always fixed or binding as the Golvatinib Price is obtained through a variety of data sources. The Golvatinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Golvatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Golvatinib, including repackagers and relabelers. The FDA regulates Golvatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Golvatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Golvatinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Golvatinib supplier is an individual or a company that provides Golvatinib active pharmaceutical ingredient (API) or Golvatinib finished formulations upon request. The Golvatinib suppliers may include Golvatinib API manufacturers, exporters, distributors and traders.
click here to find a list of Golvatinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Golvatinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Golvatinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Golvatinib GMP manufacturer or Golvatinib GMP API supplier for your needs.
A Golvatinib CoA (Certificate of Analysis) is a formal document that attests to Golvatinib's compliance with Golvatinib specifications and serves as a tool for batch-level quality control.
Golvatinib CoA mostly includes findings from lab analyses of a specific batch. For each Golvatinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Golvatinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Golvatinib EP), Golvatinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Golvatinib USP).